Crohn's Disease Treatment Market Report 2026

Crohn's Disease Treatment Market Overview

• Crohn's Disease Treatment market size has reached to $13.1 billion in 2025 • Expected to grow to $18.86 billion in 2030 at a compound annual growth rate (CAGR) of 7.8% • Growth Driver: Rising Prevalence Of Inflammatory Bowel Disorders Drives Growth Of Crohn's Disease Treatment Market • Market Trend: Innovating New Drugs To Transform The Crohn’s Disease Treatment Landscape • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Crohn's Disease Treatment Market?

Crohn's disease treatment refers to medical intervention and therapies used to manage Crohn's disease, a chronic pathological condition of the gastrointestinal tract. The treatment aims are to reduce inflammation in the intestines, prevent flare-ups of symptoms, and maintain recovery. The main drug types of Crohn’s disease treatment include antibiotics, aminosalicylates, corticosteroids, immunomodulators, and others. Antibiotics are drugs used for the treatment and prevention of bacterial infections. They are distributed through various channels such as hospital pharmacies, retail pharmacies, and online pharmacies for use in applications including neuropathic pain, fibromyalgia, chronic back pain, arthritic pain, migraine post-operative pain, cancer pain, and others.

What Is The Crohn's Disease Treatment Market Growth Forecast?

The crohn's disease treatment market size is expected to see strong growth in the next few years. It will grow to $18.86 billion in 2030 at a compound annual growth rate (CAGR) of 7.8%. The growth in the forecast period can be attributed to pipeline expansion of biologics and small molecules, rising demand for personalized treatment, growth of online pharmacy penetration, increasing healthcare expenditure in emerging markets, long-term disease management focus. Major trends in the forecast period include rising adoption of biologic therapies, shift toward early and aggressive treatment approaches, increasing focus on steroid-sparing regimens, growth of oral small-molecule therapies, expansion of online and specialty pharmacy channels.

Global Crohn's Disease Treatment Market Segmentation

1) By Drug Type: Antibiotics, Amino Salicylates, Corticosteroids, Immunomodulators, Other Drug Types 2) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies 3) By Application: Neuropathic Pain, Fibromyalgia, Chronic Back Pain, Arthritic Pain, Migraine Post-Operative Pain, Cancer Pain, Other Applications Subsegments: 1) By Antibiotics: Metronidazole, Ciprofloxacin, Other Antibiotics 2) By Amino Salicylates: Mesalamine, Sulfasalazine, Other Amino Salicylates 3) By Corticosteroids: Prednisone, Budesonide, Other Corticosteroids 4) By Immunomodulators: Azathioprine, Methotrexate, Mercaptopurine 5) By Other Drug Types: Biologics, Small Molecules, Other Treatments

What Is The Driver Of The Crohn's Disease Treatment Market?

The increase in the prevalence of inflammatory bowel disorders is expected to propel the growth of the Crohn's disease treatment market going forward. Inflammatory bowel disorders refer to a group of chronic conditions involving gastrointestinal tract inflammation. It can cause inflammation and damage to any part of the digestive system, from the mouth to the anus. Crohn's disease helps by decreasing the inflammation of the intestine, to prevent flare-ups of symptoms, and to keep in remission. For instance, in September 2023, according to the National Center for Biotechnology Information, a US-based government organization, the prevalence of Crohn’s disease and ulcerative colitis has similarly increased, with inflammatory bowel disease projected at 825 cases per 100,000 people in 2023, 410 for Crohn’s disease and 414 for ulcerative colitis and IBD-u. As a result, the rising prevalence of these disorders is fueling the expansion of the Crohn's disease treatment industry.

Key Players In The Global Crohn's Disease Treatment Market

Major companies operating in the crohn's disease treatment market are AbbVie Inc., Janssen Pharmaceuticals, Takeda Pharmaceutical Company Limited, Bristol-Myers Squibb Company, Galapagos NV, Teva Pharmaceutical Industries Ltd., Mylan N.V., Glenmark Pharmaceuticals, Tillotts Pharma AG, Dr. Falk Pharma GmbH, Shire Pharmaceuticals, Salix Pharmaceuticals, Prometheus Laboratories Inc., Pfizer Inc., Novartis AG, Sanofi S.A., Eli Lilly and Company, Boehringer Ingelheim GmbH, Arena Pharmaceuticals Inc., F. Hoffmann-La Roche Ltd.

Global Crohn's Disease Treatment Market Trends and Insights

Major companies operating in the crohn’s disease treatment market are innovating new drugs and getting them approved, such as biosimilar ustekinumab, to provide more effective and accessible treatment options for patients, ultimately improving patient outcomes and quality of life. Biosimilar ustekinumab refers to a biologic drug highly similar to the original ustekinumab (a monoclonal antibody) used for treating autoimmune conditions. For instance, in July 2024, Sandoz International GmbH, a Switzerland-based pharmaceutical company, launched Pyzchiva (ustekinumab) across Europe, marking it as the first ustekinumab biosimilar available in all strengths, including a 130 mg vial specifically for Crohn’s disease. This product is indicated for adults and children over six with plaque psoriasis, psoriatic arthritis, and Crohn’s disease, enhancing Sandoz's immunology portfolio while aiming to improve access to affordable treatments for chronic inflammatory disease.

What Are Latest Mergers And Acquisitions In The Crohn's Disease Treatment Market?

In June 2023, Merck, a US-based pharmaceutical company, acquired Prometheus Biosciences, Inc for an undisclosed amount. Through this acquisition, Merck aims to strengthen its pipeline in autoimmune diseases by adding Prometheus’ novel therapies for Crohn’s disease, ulcerative colitis, and other gastrointestinal disorders. Prometheus Biosciences Inc. is US-based develops and manufactures targeted therapies specifically for Crohn’s disease and related autoimmune conditions.

Regional Insights

North America was the largest region in the global Crohn's disease treatment market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the crohn's disease treatment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the crohn's disease treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Crohn's Disease Treatment Market?

The Crohn’s disease treatment market consists of sales of vedolizumab, methotrexate, and infliximab. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Crohn's Disease Treatment Market Report 2026?

The crohn's disease treatment market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the crohn's disease treatment industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.